Small-molecule inhibitors of the budded-to-hyphal-form transition in the pathogenic yeast Candida albicans.
The pathogenic yeast Candida albicans can exist in multiple morphological states, including budded, pseudohyphal, and true hyphal forms. The ability to convert between the budded and hyphal forms, termed the budded-to-hyphal-form transition, is important for virulence and is regulated by multiple environmental and cellular signals. To identify inhibitors of this morphological transition, a microplate-based morphological assay was developed. With this assay, the known actin-inhibiting drugs latrunculin-A and jasplakinolide were shown to inhibit the transition in a dose-dependent and reversible manner. Five novel small molecules that reversibly inhibited the transition and hyphal elongation without affecting budded growth were identified. These molecules inhibited hyphal growth induced by Spider, Lee's, M199 pH 8, and 10% serum-containing media, with two molecules having a synergistic effect. The molecules also differentially affected the hyphal form-specific gene expression of HWP1 and endocytosis without disrupting the actin cytoskeleton or septin organization. Structural derivatives of one of the molecules were more effective inhibiters than the original molecule, while other derivatives had decreased efficacies. Several of the small molecules were able to reduce C. albicans-dependent damage to endothelial cells by inhibiting the budded-to-hyphal-form transition. These studies substantiated the effectiveness of the morphological assay and identified several novel molecules that, by virtue of their ability to inhibit the budded-to-hyphal-form transition, may be exploited as starting points for effective antifungal therapeutics in the future.
Toenjes
Kurt A
KA
Department of Microbiology and Molecular Genetics, 202 Stafford Hall, 95 Carrigan Dr., University of Vermont, Burlington, VT 05405, USA.
Munsee
Suzanne M
SM
Ibrahim
Ashraf S
AS
Jeffrey
Rachel
R
Edwards
John E
JE
Johnson
Douglas I
DI
D000935:Antifungal Agents / Q000494:pharmacology*; D002176:Candida albicans / Q000187:drug effects* / Q000254:growth & development; D004705:Endocytosis; D042783:Endothelial Cells / Q000187:drug effects; D006801:Humans; D025301:Hyphae / Q000187:drug effects* / Q000502:physiology
D000935:Antifungal Agents
Mol Biol Cell. 2002 Aug;13(8):2732-46
12181342
Sabouraudia. 1975 Jul;13(2):148-53
808868
Eukaryot Cell. 2002 Apr;1(2):213-28
12455956
Eukaryot Cell. 2002 Dec;1(6):856-64
12477786
Chem Biol. 2002 Dec;9(12):1275-85
12498880
Mol Microbiol. 2000 Jan;35(2):386-96
10652099
Mycopathologia. 1984 Mar 15;85(1-2):21-30
6374461
Mol Cell Biol. 1986 Jan;6(1):142-9
3023819
Antimicrob Agents Chemother. 1988 Aug;32(8):1154-7
3190203
J Oral Pathol Med. 1991 Nov;20(10):467-72
1753348
Infect Immun. 1993 Sep;61(9):3648-55
8359888
Microbiology. 1994 Feb;140 ( Pt 2):271-80
8180692
Microbiology. 1994 Feb;140 ( Pt 2):281-7
8180693
J Am Acad Dermatol. 1994 Sep;31(3 Pt 2):S2-5
8077502
Science. 1994 Dec 9;266(5191):1723-6
7992058
Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):13217-22
8917571
Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):13223-8
8917572
EMBO J. 1997 Apr 15;16(8):1982-91
9155024
Curr Biol. 1997 Aug 1;7(8):539-46
9259554
Cell. 1997 Sep 5;90(5):939-49
9298905
Microbiology. 1997 Sep;143 ( Pt 9):3033-44
9308185
Clin Microbiol Rev. 1998 Apr;11(2):382-402
9564569
Infect Immun. 1998 Jun;66(6):2713-21
9596738
J Bacteriol. 1999 Mar;181(6):1868-74
10074081
Curr Opin Microbiol. 1998 Dec;1(6):687-92
10066539
Trends Biochem Sci. 1999 Aug;24(8):317-20
10431176
Trends Microbiol. 1999 Aug;7(8):333-8
10431207
J Bacteriol. 1999 Sep;181(17):5273-9
10464197
Clin Infect Dis. 1999 Aug;29(2):239-44
10476719
J Bacteriol. 1999 Oct;181(20):6339-46
10515923
Genetics. 2000 May;155(1):57-67
10790384
Infect Immun. 2000 Jun;68(6):3485-90
10816502
Microbiol Mol Biol Rev. 2000 Dec;64(4):746-85
11104818
Mol Cell Biol. 2001 Feb;21(4):1272-84
11158313
Microbiology. 2001 Apr;147(Pt 4):879-89
11283284
J Bacteriol. 2001 May;183(10):3211-23
11325951
Infect Immun. 2001 Dec;69(12):7898-903
11705974
Mol Microbiol. 2001 Nov;42(3):673-87
11722734
J Infect Dis. 2002 Feb 15;185(4):521-30
11865405
Mol Microbiol. 2002 May;44(3):841-53
11994163
Cell Microbiol. 2002 Aug;4(8):471-82
12174082
Mol Microbiol. 2003 May;48(4):1029-42
12753194
Eukaryot Cell. 2003 Jun;2(3):411-21
12796286
Infect Immun. 2003 Jul;71(7):4045-51
12819094
Microbiology. 2003 Oct;149(Pt 10):2977-86
14523129
Infect Immun. 2004 Jan;72(1):598-601
14688143
Proc Natl Acad Sci U S A. 2004 May 11;101(19):7433-8
15123807
Eukaryot Cell. 2004 Jun;3(3):724-34
15189993
Clin Infect Dis. 2002 Nov 1;35(9):1073-80
12384841